Stockreport

MannKind to Establish Boston-Area Research & Development Foothold and Expand Portfolio of Dry Powder Inhalation Technology in Transaction With Pulmatrix [Yahoo! Finance]

MannKind Corporation  (MNKD) 
Last mannkind corporation earnings: 2/25 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.mannkindcorp.com/press-releases
PDF Non-cash deal includes royalty-free iSPERSE ™ technology license in exchange for access to MannKind's Cricket ® inhaler DANBURY, Conn. and WESTLAKE VILLAGE, Calif., M [Read more]